All deaths | Actual place of death | |||||
Hospital n = 517 (58.0%) | Home n = 178 (20.0%) | Care home n = 106 (11.9%) | Hospice n = 91 (10.2%) | |||
Gender | ||||||
Male (%) | 520 (58.3) | 319 (61.7) | 108 (60.7) | 42 (39.6) | 51 (56.0) | |
Age at death (years, %) | ||||||
≤74 | 363 (40.7) | 231 (44.7) | 80 (44.9) | 7 (6.6) | 45 (49.5) | |
75+ | 529 (59.3) | 286 (55.3) | 98 (55.1) | 99 (93.4) | 46 (50.5) | |
IMD category* (%) | ||||||
Most affluent | 1 | 328 (36.8) | 196 (38.0) | 63 (35.4) | 35 (33.0) | 34 (37.4) |
2 | 303 (34.0) | 165 (32.0) | 64 (36.0) | 44 (41.5) | 30 (33.0) | |
Most deprived | 3 | 260 (29.2) | 155 (30.0) | 51 (28.7) | 27 (25.5) | 27 (29.7) |
First diagnosis (%) | ||||||
DLBCL† | 129 (14.5) | 71 (13.7) | 23 (12.9) | 22 (20.8) | 13 (14.3) | |
Myeloma | 145 (16.3) | 90 (17.4) | 35 (19.7) | 11 (10.4) | 9 (9.9) | |
AML‡ | 101 (11.3) | 61 (11.8) | 22 (12.4) | 7 (6.6) | 11 (12.1) | |
MDS§ | 107 (12.0) | 69 (13.3) | 22 (12.4) | 6 (5.7) | 10 (11.0) | |
CLL¶ | 89 (10.0) | 49 (9.5) | 18 (10.1) | 12 (11.3) | 10 (11.0) | |
MPN** | 79 (8.7) | 34 (6.6) | 20 (11.2) | 18 (17.0) | 6 (6.6) | |
Other | 243 (27.2) | 143 (27.7) | 38 (21.3) | 30 (28.3) | 32 (35.2) | |
Time from diagnosis to death (%) | ||||||
0–6 months | 211 (23.7) | 138 (26.7) | 34 (19.1) | 27 (25.5) | 12 (13.2) | |
6+ months | 681 (76.3) | 379 (73.3) | 144 (80.9) | 79 (74.5) | 79 (86.8) | |
Underlying cause of death†† | ||||||
Haematological malignancy (%) | 602 (67.5) | 353 (68.3) | 117 (65.7) | 64 (60.4) | 68 (74.7) | |
Patient lived alone | ||||||
Yes (%) | 247 (27.7) | 144 (27.9) | 45 (25.3) | 22 (20.8) | 36 (39.6) | |
Hospital-based SPC‡‡ referral | ||||||
Yes (%) | 319 (35.8) | 167 (32.3) | 66 (37.1) | 19 (17.9) | 67 (73.6) | |
Preferred place of death discussion recorded | ||||||
Yes (%) | 453 (50.8) | 217 (42.0) | 103 (57.9) | 61 (57.5) | 72 (79.1) |
*Index of Multiple Deprivation (income domain): one patient with missing data.
†Diffuse large B-cell lymphoma.
‡Acute myeloid leukaemia.
§Myelodysplastic syndromes.
¶Chronic lymphocytic leukaemia.
**Myeloproliferative neoplasms.
††Derived from death certificate data, Medical Research Information Service.
‡‡Specialist palliative care.